公司概覽
業務類別 Diagnostics & Research
業務概覽 Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ inthe office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx derives roughly 35% of its revenue from outside the United States.
公司地址 One IDEXX Drive, Westbrook, ME, USA, 04092
電話號碼 +1 207 556-0300
傳真號碼 +1 207 556-4346
公司網頁 https://www.idexx.com
員工數量 11000
 
公司高管 / 董事會成員
公司高管
高管 職務 年薪 更新日期
Mr. George J. Fennell Executive Vice President, Global CAG Commercial -- 27/03/2026
Dr. Martin Alexander Smith, PhD Executive Vice President, Global Operations and Research and Development 美元 594.05K 27/03/2026
Ms. Sharon E. Underberg Executive Vice President, General Counsel and Corporate Secretary -- 27/03/2026
Mr. Michael J. Lane Executive Vice President and General Manager, Global Reference Laboratories, Diagnostic Solutions and Information Technology 美元 594.05K 27/03/2026
Mr. Michael P. Johnson Senior Vice President and Chief Human Resources Officer -- 27/03/2026
Dr. Michael G. Erickson, PhD Director, President and Chief Executive Officer -- 13/01/2026
Mr. Michael Schreck Executive Vice President and General Manager, Veterinary Software and Services, Corporate Accounts and Customer Experience -- 27/03/2026
Mr. Andrew J. Emerson Executive Vice President, Chief Financial Officer, Treasurer and Principal Accounting Officer 美元 531.15K 27/03/2026
 
董事會成員
董事會 職務 更新日期
Mr. Bruce L. Claflin Independent Director 27/03/2026
Mr. Daniel M. Junius Independent Director 27/03/2026
Mr. Joseph L. Hooley Lead Independent Director 27/03/2026
Mr. Lawrence D. Kingsley Non-Executive Chairman of the Board 27/03/2026
Dr. Sophie V. Vandebroek, PhD Independent Director 27/03/2026
Mr. Stuart M. Essig, PhD Independent Director 27/03/2026
Ms. Irene Chang Britt Independent Director 27/03/2026
Mr. Jonathan J. Mazelsky Executive Chairman of the Board 13/01/2026
Mr. Sam A. Samad Independent Director 27/03/2026
Ms. Karen A. Peacock Independent Director 27/03/2026
Dr. Michael G. Erickson, PhD Director, President and Chief Executive Officer 13/01/2026
 
所屬ETF (更新日期: 14/11/2026 03:50)
代號 名稱 佔比% ▼ 持有日期
CFAVictoryShares US 500 Volatility Wtd ETF0.003%30/10/2026
EFIVState Street SPDR S&P500 Scrd&ScrndETF0.003%30/10/2026
QDPLPacer Metaurus US Lg Cp Dvd Mltp 400 ETF0.003%30/10/2026
HLALWahed FTSE USA Shariah ETF0.002%30/10/2026
QQHHCM Defender 100 Index ETF0.002%30/10/2026
APUEActivePassive U.S. Equity ETF0.002%30/10/2026
TSPAT. Rowe Price US Equity Research ETF0.002%30/09/2026
DFVXDimensional US Large Cap Vector ETF0.002%30/10/2026
MEDIHarbor Health Care ETF0.002%31/10/2026
TDAQTappAlpha Innovation 100 Gr & Dl Inc ETF0.002%30/10/2026
JSTCAdasina Social Justice All Cp Glbl ETF0.002%30/10/2026
MODLVictoryShares WestEnd U.S. Sector ETF0.002%30/10/2026
CFOVictoryShares US 500 Enh Vol Wtd ETF0.002%30/10/2026
CUREDirexion Daily Healthcare Bull 3X ETF0.002%31/10/2026
TILTNorthern Trust Mstar US Mkt Fac Tlt ETF0.002%30/10/2026
MLRGiShares MSCI USA ETF0.002%30/10/2026
EQALInvesco Russell 1000 Equal Weight ETF0.002%30/10/2026
DXUVDimensional US Vector Equity ETF0.002%24/09/2026
SIZEiShares MSCI USA Size Factor ETF0.002%30/10/2026
PSEPInnovator US Equity Power Buffer ETF-Sep0.002%30/10/2026
  1    2    3    4    5    6    7    8   9    10    11    12    13    14    15    16    17    18    19    20    21  
 

Copyright © 2026 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.